Once FBP1 promoter methylation was detected at a high frequency in primary carcinoma tissues but not non-tumor normal gastric tissues, FBP1 promoter methylation may be a potential biomarker for cancer diagnosis. The gene discussed is FBP1; the disease is carcinoma.